Saving Lives With Limula’s Machine For Industrializing Cell Therapy
“When you’re in the early stages of a gold rush, it makes sense to be the one providing the tools,” says Luc Henry, co-founder of Limula. The Swiss start-up, which is today announcing a $6.8 million funding round, wants to play that role as investment in cell and gene therapy, a hugely exciting new area of medicine, continues to accelerate.
